Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients

Table 4 Influence of BMI stratum on the effect of FPV/r on the serum cholesterol level after 6 months of PI therapy

Parameter	Coefficient	p-value
ATV/r	reference
SQV/r	36.6	0.004
FPV/r
for BMI >23.5 kg/m²	58.1	<0.001
for BMI ≤23.5 kg/m²	36.6	0.023
Serum cholesterol at baseline	0.5	<0.001
BMI of >23.5 kg/m ² at baseline	15.0	0.13

ISSN: 2047-783X